These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 1677060)
1. Medical treatment of peptic ulcer disease. Rubin W Med Clin North Am; 1991 Jul; 75(4):981-98. PubMed ID: 1677060 [TBL] [Abstract][Full Text] [Related]
2. Medical treatment of peptic ulcers. Deveney CW; Deveney KE Surg Annu; 1985; 17():219-33. PubMed ID: 3883541 [TBL] [Abstract][Full Text] [Related]
3. Medical therapy of peptic ulcer disease. McQuaid KR; Isenberg JI Surg Clin North Am; 1992 Apr; 72(2):285-316. PubMed ID: 1347960 [TBL] [Abstract][Full Text] [Related]
4. Drugs for treatment of peptic ulcers. Dajani EZ; Trotman BW J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999 [TBL] [Abstract][Full Text] [Related]
5. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression. Lad R; Armstrong D Can J Gastroenterol; 1999 Mar; 13(2):135-42. PubMed ID: 10203432 [TBL] [Abstract][Full Text] [Related]
7. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update. Dajani EZ; Agrawal NM J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335 [TBL] [Abstract][Full Text] [Related]
8. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate. Bianchi Porro G; Parente F J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic approach to ulcer healing. Blum AL Am J Med; 1985 Aug; 79(2C):8-14. PubMed ID: 2863981 [TBL] [Abstract][Full Text] [Related]
10. Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers. Deakin M; Williams JG Drugs; 1992 Nov; 44(5):709-19. PubMed ID: 1280563 [TBL] [Abstract][Full Text] [Related]
14. Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists. Tytgat GN; Lamers CB; Hameeteman W; Jansen JM; Wilson JA Aliment Pharmacol Ther; 1987 Feb; 1(1):31-8. PubMed ID: 2908747 [TBL] [Abstract][Full Text] [Related]
15. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy. McCarthy DM J Clin Gastroenterol; 1990; 12 Suppl 2():S13-20. PubMed ID: 1978842 [TBL] [Abstract][Full Text] [Related]
16. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease. Tytgat GN; Nio CY Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894 [TBL] [Abstract][Full Text] [Related]
17. Drugs for treatment of peptic ulcers. Med Lett Drugs Ther; 1991 Nov; 33(858):111-4. PubMed ID: 1682791 [No Abstract] [Full Text] [Related]
18. Advances in the treatment of peptic ulcer disease. Camara DS Compr Ther; 1987 Aug; 13(8):13-6. PubMed ID: 2887333 [No Abstract] [Full Text] [Related]
19. The pathophysiological and pharmacological basis of peptic ulcer therapy. Freston JW Toxicol Pathol; 1988; 16(2):260-6. PubMed ID: 2903542 [TBL] [Abstract][Full Text] [Related]
20. The other option in peptic ulcer therapy. Halter F S Afr Med J; 1984 Jun; 65(25):996-1000. PubMed ID: 6374932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]